Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | SZ4TA2 | CTRPv2 | pan-cancer | AAC | 0.018 | 0.7 |
mRNA | SB-525334 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.7 |
mRNA | GSK2636771 | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | BRD-K30019337 | CTRPv2 | pan-cancer | AAC | 0.022 | 0.8 |
mRNA | BRD-K26531177 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.8 |
mRNA | Crizotinib | CTRPv2 | pan-cancer | AAC | 0.01 | 0.8 |
mRNA | CD-1530 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.8 |
mRNA | tipifarnib | CTRPv2 | pan-cancer | AAC | 0.01 | 0.8 |
mRNA | GW-405833 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
mRNA | salermide | CTRPv2 | pan-cancer | AAC | 0.015 | 0.8 |